Six New Assays Added to Specialist Protein Analyzer
By LabMedica International staff writers Posted on 27 Feb 2012 |
Image: SPAplus protein analyzer with kit (Photo courtesy of Binding Site).
Six fully automated, easy-to-use assays were added to a specialist protein analyzer. They provide quantitative results to aid the assessment of a patient’s immune system.
The six assays include four cerebrospinal fluid (CSF) assays: immunoglobulin G (IgG), IgA, IgM, and albumin. Complement 1(C1) inactivator in plasma and serum, for the investigation of hereditary angioedema, and transferrin in serum, for estimation of iron deficiency anaemia, were also added to the analyzer menu.
These additions complement the panel of assays currently available on SPAplus including Hevylite immunoglobulin heavy chain/light chain assays, Freelite serum free light chain assays, and various complement assays.
Binding Site’s (Birmingham, United Kingdom) SPAplus specialist protein analyzer was designed to bring together instrument, reagents, and support as a package. A compact, turbidimetric platform, the fully automated SPAPLUS system enables laboratories to maintain the quality of results and high throughput required for specialized protein assays. It can be placed alongside the laboratory’s main-line analyzers or in other areas of the laboratory.
Preprogrammed protocols, developed and manufactured by Binding Site, provide sensitive and reproducible results that match or have greater sensitivity than nephelometry. The modular design with intuitive Windows based software makes the SPAplus very easy to use.
SPAplus has an expanding menu of diagnostic tests related to disease state management and clinical practice guidelines. More assays will be added during 2012.
Related Links:
Binding Site
The six assays include four cerebrospinal fluid (CSF) assays: immunoglobulin G (IgG), IgA, IgM, and albumin. Complement 1(C1) inactivator in plasma and serum, for the investigation of hereditary angioedema, and transferrin in serum, for estimation of iron deficiency anaemia, were also added to the analyzer menu.
These additions complement the panel of assays currently available on SPAplus including Hevylite immunoglobulin heavy chain/light chain assays, Freelite serum free light chain assays, and various complement assays.
Binding Site’s (Birmingham, United Kingdom) SPAplus specialist protein analyzer was designed to bring together instrument, reagents, and support as a package. A compact, turbidimetric platform, the fully automated SPAPLUS system enables laboratories to maintain the quality of results and high throughput required for specialized protein assays. It can be placed alongside the laboratory’s main-line analyzers or in other areas of the laboratory.
Preprogrammed protocols, developed and manufactured by Binding Site, provide sensitive and reproducible results that match or have greater sensitivity than nephelometry. The modular design with intuitive Windows based software makes the SPAplus very easy to use.
SPAplus has an expanding menu of diagnostic tests related to disease state management and clinical practice guidelines. More assays will be added during 2012.
Related Links:
Binding Site
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms